<table border="single" id="id_639550be-b2ed-4867-bb35-7a598ca325f0" width="482.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_a1b30c8a-d85c-44c3-a515-f897a35b80cf">Table 6. Drugs That Should Not Be Coadministered With RESCRIPTOR</caption>
<col width="34.6%"></col>
<col width="65.4%"></col>
<tbody>
<tr id="id_67364138-109c-4e35-b6ff-7b40c9c87578">
<td align="center" stylecode="Botrule Toprule Rrule Lrule" valign="top">Drug Class: Drug Name</td>
<td align="center" stylecode="Botrule Rrule" valign="top">Clinical Comment</td>
</tr>
<tr id="id_d5ea45d5-944e-45e2-a9ea-6e73edef5c50">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">Anticonvulsant agents:</content>
</paragraph>Phenytoin, phenobarbital, carbamazepine</td>
<td align="left" stylecode="Botrule Rrule" valign="top">May lead to loss of virologic response and possible resistance to RESCRIPTOR or to the class of NNRTIs.</td>
</tr>
<tr id="id_1205202c-de13-4861-820a-05fd89801eb4">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">Antihistamines:</content>
</paragraph>Astemizole, terfenadine</td>
<td align="left" stylecode="Botrule Rrule" valign="top">CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias.</td>
</tr>
<tr id="id_0c0a0a2c-55fd-4302-8e17-5803622f3f4f">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">Antimycobacterials: </content>
</paragraph>Rifabutin,<sup>a</sup> rifampin<sup> a</sup>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">May lead to loss of virologic response and possible resistance to RESCRIPTOR or to the class of NNRTIs or other coadministered antiviral agents.</td>
</tr>
<tr id="id_725b68f9-a9f1-46ca-824f-d81fdad0f383">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">Ergot Derivatives:</content>
</paragraph>Dihydroergotamine, ergonovine, ergotamine, methylergonovine</td>
<td align="left" stylecode="Botrule Rrule" valign="top">CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.</td>
</tr>
<tr id="id_325fac39-c742-45d5-bdaa-9df70dea5943">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">GI motility agent:</content>
</paragraph>Cisapride</td>
<td align="left" stylecode="Botrule Rrule" valign="top">CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias.</td>
</tr>
<tr id="id_3553bf1c-0137-4186-9ead-b697cef3ca3d">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">Herbal Products:</content>
</paragraph>St. Johnâ€™s wort <br/>( <content stylecode="italics">hypericum perforatum</content>)</td>
<td align="left" stylecode="Botrule Rrule" valign="top">May lead to loss of virologic response and possible resistance to RESCRIPTOR or to the class of NNRTIs.</td>
</tr>
<tr id="id_2192a4d9-26ac-4381-96f7-6577e9272ab2">
<td align="justify" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">HMG-CoA reductase inhibitors:</content>
</paragraph>Lovastatin, simvastatin</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Potential for serious reactions such as risk of myopathy including rhabdomyolysis.</td>
</tr>
<tr id="id_128f7e6a-1cf4-4da9-8569-f987e134d855">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">Neuroleptic:</content>
</paragraph>Pimozide</td>
<td align="left" stylecode="Botrule Rrule" valign="top">CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias.</td>
</tr>
<tr id="id_1be711f9-ab7d-46f7-9d64-83dd78e6feb1">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">Sedative/hypnotics:</content>
</paragraph>Alprazolam, midazolam, triazolam</td>
<td align="left" stylecode="Botrule Rrule" valign="top">CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.</td>
</tr>
</tbody>
</table>